erythrosine has been researched along with morphine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Rubenstein, KE; Schwarzberg, M; Ullman, EF | 1 |
Baba, M; Oishi, R; Saeki, K | 1 |
Ayling, P; Colbert, DL; Gallacher, G; Turner, GJ | 1 |
Khanna, PL; Ullman, EF | 1 |
Endo, T; Hara, S; Iwata, N; Kano, S; Kawaguchi, N; Kuriiwa, F | 1 |
Kim, JS; Lemasters, JJ | 1 |
Armstrong, EA; Black, AM; Clark, D; Pandya, S; Yager, JY | 1 |
Heller, NM; Maher, DP; Walia, D | 1 |
Hauser, KF; Jones, AM; Kim, WK; Knapp, PE; Leibrand, CR; McRae, M; Nass, SR; Ohene-Nyako, M; Paris, JJ; Rademeyer, KM | 1 |
9 other study(ies) available for erythrosine and morphine
Article | Year |
---|---|
Fluorescent excitation transfer immunoassay. A general method for determination of antigens.
Topics: Animals; Antigens; Binding Sites; Chromatography, Affinity; Fluoresceins; Humans; Immunoassay; Immunoglobulin G; Macromolecular Substances; Mathematics; Morphine; Protein Binding; Protein Conformation; Rabbits; Spectrometry, Fluorescence | 1976 |
Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice.
Topics: Animals; Blood-Brain Barrier; Buprenorphine; Carbon Dioxide; Fluorescein; Fluoresceins; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Mice; Mice, Inbred Strains; Morphine; Narcotics; Pentazocine; Receptors, Opioid; Receptors, Opioid, mu; Time Factors | 1988 |
Development of fluoroimmunoassays for the specific detection of morphine in urine.
Topics: Chromatography, Thin Layer; Codeine; Cross Reactions; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescence Polarization; Humans; Immunoassay; Morphine; Morphine Derivatives; Papaver; Plants, Medicinal; Thiocyanates | 1988 |
4',5'-Dimethoxy-6-carboxyfluorescein: a novel dipole-dipole coupled fluorescence energy transfer acceptor useful for fluorescence immunoassays.
Topics: Antibodies; Energy Transfer; Fluoresceins; Fluorescent Antibody Technique; Indicators and Reagents; Morphine; Proteins; Spectrometry, Fluorescence; Spectrophotometry | 1980 |
Involvement of opioid receptors in shaking behaviour induced by paraquat in rats.
Topics: Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Drug Combinations; Fluorescein; Fluoresceins; Injections, Intraperitoneal; Injections, Intraventricular; Male; Morphine; Motor Activity; Naloxone; Paraquat; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 1993 |
Opioid receptor-independent protection of ischemic rat hepatocytes by morphine.
Topics: Animals; Cells, Cultured; Cytoprotection; Fluoresceins; Hepatocytes; Hypoxia; Ischemia; Microscopy, Confocal; Morphine; Nitric Oxide; Oxygen; Potassium Channel Blockers; Potassium Channels; Rats; Receptors, Opioid | 2006 |
Effect of caffeine and morphine on the developing pre-mature brain.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain; Caffeine; Cell Count; Central Nervous System Stimulants; Female; Fluoresceins; Male; Morphine; Narcotics; Neurons; Organic Chemicals; Pregnancy; Random Allocation; Rats; Rats, Long-Evans; Time Factors | 2008 |
Suppression of Human Natural Killer Cells by Different Classes of Opioids.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol | 2019 |
Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner.
Topics: Animals; Corpus Striatum; Dextrans; Fluoresceins; HIV Infections; HIV-1; Humans; Macrophages; Mice; Mice, Transgenic; Morphine; Opioid-Related Disorders; Sulfonic Acids; tat Gene Products, Human Immunodeficiency Virus | 2022 |